₹ 25.49
-0.21 (-0.82%)
BSE
B
Beryl Drugs
₹ 25.49
BSE
BERLDRG Financials Summary
Beryl Drugs revenue increased 38.18% quarter-on-quarter to ₹8 Cr in Jun 2026, while net profit decreased 66.67% quarter-on-quarter to ₹0 Cr. Compared to the same quarter last year, revenue is up 58.33% and net profit stood at ₹0 Cr versus nil a year ago. EPS for the quarter stood at ₹0.44, decreased from ₹1.11 in the previous quarter and up from ₹0.04 a year ago.
Beryl Drugs Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of BERLDRG Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
BERLDRG Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






